Humana Inc. (NYSE:HUM) Shares Sold by Creative Planning

Creative Planning reduced its position in shares of Humana Inc. (NYSE:HUM) by 8.6% during the third quarter, Holdings Channel.com reports. The fund owned 24,245 shares of the insurance provider’s stock after selling 2,273 shares during the quarter. Creative Planning’s holdings in Humana were worth $7,680,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Pzena Investment Management LLC lifted its position in shares of Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after acquiring an additional 1,955,375 shares during the last quarter. Davis Selected Advisers raised its position in shares of Humana by 16.1% during the second quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock worth $863,640,000 after purchasing an additional 321,233 shares during the period. Marshall Wace LLP lifted its holdings in shares of Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after purchasing an additional 774,085 shares during the last quarter. Legal & General Group Plc boosted its position in shares of Humana by 2.1% in the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock valued at $442,396,000 after purchasing an additional 24,842 shares during the period. Finally, Ontario Teachers Pension Plan Board increased its stake in Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after purchasing an additional 1,050,459 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

HUM has been the subject of a number of analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a research note on Tuesday, October 1st. Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Oppenheimer lowered their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research note on Thursday, October 3rd. Bank of America downgraded Humana from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $376.00 to $247.00 in a research note on Wednesday, October 2nd. Finally, KeyCorp started coverage on Humana in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. One equities research analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $315.33.

Humana Price Performance

Shares of NYSE:HUM opened at $258.61 on Thursday. The company has a market cap of $31.16 billion, a price-to-earnings ratio of 16.10, a PEG ratio of 1.91 and a beta of 0.50. The business has a 50 day moving average price of $310.28 and a 200 day moving average price of $337.43. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the prior year, the business earned $8.94 earnings per share. Humana’s revenue for the quarter was up 10.4% compared to the same quarter last year. Research analysts predict that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be given a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.37%. Humana’s dividend payout ratio is 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.